Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Short-term Investments (2022 - 2025)

Mesa Laboratories' Short-term Investments history spans 4 years, with the latest figure at $1.8 million for Q1 2025.

  • For Q1 2025, Short-term Investments fell 7.69% year-over-year to $1.8 million; the TTM value through Mar 2025 reached $1.8 million, down 7.69%, while the annual FY2025 figure was $1.8 million, 7.69% down from the prior year.
  • Short-term Investments for Q1 2025 was $1.8 million at Mesa Laboratories, up from $1.3 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $2.8 million in Q3 2022 and bottomed at $1.3 million in Q4 2024.
  • The 4-year median for Short-term Investments is $1.6 million (2022), against an average of $1.7 million.
  • The largest annual shift saw Short-term Investments surged 37.94% in 2024 before it decreased 7.69% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $1.7 million in 2022, then dropped by 18.51% to $1.4 million in 2023, then dropped by 3.53% to $1.3 million in 2024, then surged by 30.94% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Short-term Investments are $1.8 million (Q1 2025), $1.3 million (Q4 2024), and $1.5 million (Q2 2024).